Application 090252

Application Products#

Product, Drug, Ingredient table
Product	Drug	Ingredient	Form	Strength	Reference drug	Reference standard
001	REPAGLINIDE	REPAGLINIDE	TABLET;ORAL	0.5MG	No	No
002	REPAGLINIDE	REPAGLINIDE	TABLET;ORAL	1MG	No	No
003	REPAGLINIDE	REPAGLINIDE	TABLET;ORAL	2MG	No	No

NDC, Name, Nonproprietary name table
NDC	Name	Nonproprietary name	Labeler	Marketing category	Status
0378-3122	Repaglinide	repaglinide	Mylan Pharmaceuticals Inc.	ANDA	Current
0378-3123	Repaglinide	repaglinide	Mylan Pharmaceuticals Inc.	ANDA	Current
51079-539	Repaglinide	repaglinide	Mylan Institutional Inc.	ANDA	Current